Other News

FUJIFILM Sonosite deploys new Point-of-Care Ultrasound Workflow Management Solution at Kaweah Delta Medical Center’s Emergency Department

BOTHELL, Wash., Feb. 22, 2021 /PRNewswire/ — FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound solutions, announced today that Kaweah Delta Medical Center’s Emergency Department has gone live with Sonosite Synchronicity™, a comprehensive point-of-care ultrasound (POCUS) workflow solution. Sonosite Synchronicity software helps point-of-care clinicians meet administrative challenges by enabling standardized remote workflows […]

IMPULSE DYNAMICS RECEIVES APPROVAL TO SELL OPTIMIZER CCM DEVICES IN CHINA

NMPA Clears the Way for Impulse Dynamics to Deliver Hope for Heart Failure Population MARLTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF), today announced that the National Medical Products Administration (NMPA) approved the application for […]

Bracco Announces U.S. FDA Approval of 20-Vial Configuration of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use

20-vial pack provides a green packaging alternative and helps increase storage efficiency MONROE TOWNSHIP, N.J., Feb. 22, 2021 /PRNewswire/ — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business, announced today that its ultrasound enhancing agent (UEA) LUMASON® (sulfur hexafluoride lipid-type […]

Tris Pharma and Athena Bioscience Announce Exclusive License Agreement to Commercialize Near-to-Market Long-Acting Antihypertensive Product in the U.S.

MONMOUTH JUNCTION, N.J. and ATHENS, Ga., Feb. 22, 2021 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) and Athena Bioscience LLC (“Athena”) announced today that they have entered into an agreement by which Athena received exclusive rights to commercialize a long-acting antihypertensive product developed using  Tris’ proprietary technology. On average, only 50% of adults adhere to chronic […]

VALBIOTIS Announces the First Patient’s First Visit in the Phase II HEART Clinical Study on TOTUM-070 and Steps up Its Research Program Against Hypercholesterolemia in 2021

The first subject, with blood LDL-cholesterol (“bad cholesterol”) levels greater than 130 mg/dL, has undergone the initial medical examination for the HEART protocol on the active substance TOTUM-070. The HEART study will include 120 people with elevated blood LDL-cholesterol, a risk factor for cardiovascular disease and the primary endpoint of […]

RhythMedix Launches Next-Generation RhythmStar® Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity

Innovative RhythmStar® technology designed to improve cardiac monitoring for faster arrhythmia detection MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ — RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring […]

Caption Health Announces JAMA Cardiology Publication Showing Effectiveness of AI-Guided Ultrasound Software

Multicenter clinical study supported landmark FDA authorization of Caption Guidance software in February 2020 BRISBANE, Calif., Feb. 18, 2021 /PRNewswire/ — Caption Health, a leading medical artificial intelligence (AI) company providing AI guidance and interpretation for ultrasound, today announced the publication of the study that was the basis for the February 2020 authorization of Caption […]

Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results

SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2020. Recent Highlights Recognized revenue […]

Cytokinetics Names Muna Bhanji to Board of Directors

Appointment Adds to Board Expertise in Commercial Development and Market Access as Company Prepares for Further Corporate Development SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Muna Bhanji has been appointed to the company’s Board of Directors. Ms. Bhanji brings more than 30 […]

Aziyo Biologics Announces First Patient Enrolled in HEAL Study

SILVER SPRING, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the first patient enrolled in the HEAL Study, investigating the biologic and clinical […]